MedTrace Logo

Clinical Cohort Study - TRUST

NCT05521451 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 5000

Last updated 2025-03-30

No results posted yet for this study

Summary

The "Long-term Outcome and Predictors for Recurrence after Medical and Interventional Treatment of Arrhythmias at the University Heart Center Hamburg" (TRUST) study is an investor-initiated, single-center, prospective clinical cohort study including patients treated with cardiac arrhythmias or at high risk for cardiac arrhythmias. The design enables prospective, low-threshold, near complete inclusion of patients with arrhythmias treated at the UHZ. Collection of routine follow-up data, detailed procedural information and systematic biobanking will enable precise and robust phenotyping.

Conditions

  • Arrhythmias, Cardiac
  • Atrial Fibrillation
  • Atrial Flutter
  • Ventricular Tachycardia
  • Atrial Tachycardia
  • Arrhythmogenic Right Ventricular Dysplasia
  • Long QT Syndrome
  • Brugada Syndrome
  • Supraventricular Tachycardia
  • Catecholaminergic Polymorphic Ventricular Tachycardia
  • Torsades De Pointes
  • Atrial Cardiomyopathy

Sponsors & Collaborators

  • Universitätsklinikum Hamburg-Eppendorf

    lead OTHER

Principal Investigators

  • Paulus Kirchhof, MD · Universitätsklinikum Hamburg-Eppendorf

  • Andreas Metzner, MD · Universitätsklinikum Hamburg-Eppendorf

  • Andreas Rillig, MD · Universitätsklinikum Hamburg-Eppendorf

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-17
Primary Completion
2026-09-30
Completion
2031-12-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05521451 on ClinicalTrials.gov